Healogics, Inc. -- Moody's places Healogics' ratings under review for downgrade following announced purchase by private equity

New York, May 22, 2014 -- Moody's Investors Service placed the ratings of Healogics, Inc.'s. ("Healogics") under review for downgrade, including the company's B2 Corporate Family Rating, B2-PD Probability of Default Rating and all debt instrument ratings. The review was prompted by the announcement that Healogics has agreed to be acquired in a leveraged buyout led by private equity investor Clayton, Dubilier and Rice. The transaction is valued at approximately $910 million, including the assumption of about $400 million in debt. The transaction is expected to close in the third quarter of 2014.

Vollständigen Artikel bei Moodys lesen